| Literature DB >> 35204203 |
Yen-Ting Lin1, Hsiang-Ru Lin2, Chang-Syun Yang1, Chia-Ching Liaw3,4, Ping-Jyun Sung5, Yueh-Hsiung Kuo6,7,8, Ming-Jen Cheng9, Jih-Jung Chen1,6.
Abstract
Crataegus pinnatifida is used to treat various diseases, including indigestion, congestive heart failure, hypertension, atherosclerosis, and myocardial dysfunction. We evaluated antioxidant and anti-α-glucosidase activities of various solvent extracts and major bioactive components from the fruit of C. pinnatifida. Ethyl acetate extracts showed potent antioxidant activities with IC50 values of 23.26 ± 1.97 and 50.73 ± 8.03 μg/mL, respectively, in DPPH and ABTS radical scavenging assays. Acetone extract exhibited significant anti-α-glucosidase activity with IC50 values of 42.35 ± 2.48 μg/mL. HPLC analysis was used to examine and compare the content of active components in various solvent extracts. We isolated four active compounds and evaluated their antioxidant and anti-α-glucosidase properties. Among the isolated compounds, chlorogenic acid and hyperoside showed potential antioxidant activities in ABTS and superoxide radical scavenging assays. Moreover, hyperoside also displayed stronger anti-α-glucosidase activity than other isolates. The molecular docking model and the hydrophilic interactive mode of anti-α-glucosidase assay revealed that hyperoside might have a higher antagonistic effect than positive control acarbose. The present study suggests that C. pinnatifida and its active extracts and components are worth further investigation and might be expectantly developed as the candidates for the treatment or prevention of oxidative stress-related diseases and hyperglycemia.Entities:
Keywords: Crataegus pinnatifida; active components; anti-α-glucosidase activity; antioxidant activity; molecular docking; various solvent extracts
Year: 2022 PMID: 35204203 PMCID: PMC8868160 DOI: 10.3390/antiox11020320
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
TPC, TFC, and extraction yields of Crataegus pinnatifida with each extraction solvent.
| Extracting | Relative | TPC (mg/g) a | TFC (mg/g) b | Yields (%) c |
|---|---|---|---|---|
| 0.009 | 12.12 ± 0.26 * | 31.74 ± 1.07 * | 2.3 ± 1.67 | |
| Chloroform | 0.259 | 21.09 ± 0.99 ** | 37.93 ± 5.31 * | 3.2 ± 0.79 |
| Dichloromethane | 0.269 | 19.77 ± 0.13 ** | 34.87 ± 1.95 * | 9.7 ± 1.49 |
| Ethyl acetate | 0.228 | 63.53 ± 0.27 *** | 25.22 ± 4.21 * | 15.5 ± 1.13 |
| Acetone | 0.355 | 45.81 ± 0.61 *** | 19.41 ± 3.00 * | 17.1 ± 0.23 |
| Ethanol | 0.654 | 32.82 ± 1.21 *** | 22.61 ± 0.90 * | 24.1 ± 0.23 |
| Methanol | 0.762 | 44.20 ± 1.30 *** | 17.40 ± 3.11 | 28.0 ± 0.75 |
a TPC was expressed in mg of gallic acid equivalents (GAE) per gram of extract. b TFC was expressed in milligram of quercetin equivalents (QE) per gram of extract. Values are expressed as means ± standard error. c Yield was calculated as % yield = (weight of extract/initial weight of dry sample) × 100; * p < 0.05, ** p < 0.01, *** p < 0.001 compared with the control.
The antioxidant activities of different solvent extracts from Crataegus pinnatifida determined by DPPH, ABTS, superoxide, and hydroxyl radical scavenging and FRAP assays.
| Extracting | DPPH | ABTS | Superoxide | Hydroxyl | FRAP (mM/g) |
|---|---|---|---|---|---|
| 199.18 ± 16.82 * | 131.14 ± 7.15 * | >400 | 124.45 ± 6.27 * | 70.11 ± 4.13 * | |
| Chloroform | 68.61 ± 3.14 * | 141.97 ± 3.70 * | >400 | 114.41 ± 1.80 * | 149.98 ± 5.54 * |
| Dichloromethane | 76.22 ± 4.90 * | 131.44 ± 7.13 * | >400 | >400 | 154.05 ± 4.62 ** |
| Ethyl acetate | 23.26 ± 1.97 ** | 50.73 ± 8.03 * | 122.95 ± 9.07 * | 92.30 ± 7.47 * | 216.32 ± 9.13 * |
| Acetone | 40.06 ± 0.18 ** | 87.75 ± 2.70 ** | >400 | 127.25 ± 2.26 * | 264.27 ± 12.11 * |
| Ethanol | 96.21 ± 4.26 ** | 140.29 ± 6.76 * | >400 | 139.03 ± 17.33 * | 227.59 ± 10.13 * |
| Methanol | 74.13 ± 5.61 ** | 105.86 ± 6.25 * | 242.95 ± 18.51 | 138.04 ± 21.91 * | 198.94 ± 8.24 * |
| BHT a | 34.28 ± 1.40 * | 12.34 ± 0.29 * | N.A. c | 61.51 ± 2.46 * | 4257.97 ± 44.90 ** |
Results are expressed as half inhibitory concentration (IC50) of each free-radical scavenging activity. a Butylated hydroxytoluene (BHT) used as positive control. b FRAP was expressed in millimolar (mM) of Trolox equivalents (TE) per gram of extract; c N.A. indicates not available; * p < 0.05, and ** p < 0.01 compared with the control.
α-Glucosidase inhibitory activities of different solvent extracts.
| Extracting Solvents | α-Glucosidase |
|---|---|
| 99.75 ± 4.37 * | |
| Chloroform | 207.46 ± 9.52 * |
| Dichloromethane | 120.41 ± 6.44 * |
| Ethyl acetate | 126.36 ± 9.81 * |
| Acetone | 42.35 ± 2.48 ** |
| Ethanol | 58.69 ± 6.91 * |
| Methanol | 52.02 ± 0.24 ** |
| Acarbose a | 317.80 ± 16.36 * |
a Acarbose used as positive control; * p < 0.05 and ** p < 0.01 compared with the control.
Identification and quantification of the major active components from Crataegus pinnatifida in different solvent extracts.
| Extracting | Epicatechin | Chlorogenic Acid | Hyperoside | Procyanidin B2 | Total Amount |
|---|---|---|---|---|---|
| 0.45 ± 0.17 | 0.44 ± 0.28 | 0.63 ± 0.32 | 0.42 ± 0.24 | 1.92 ± 0.25 | |
| Chloroform | 1.03 ± 0.16 | 1.64 ± 0.16 | 1.26 ± 0.22 | 0.82 ± 0.13 | 4.75 ± 0.17 |
| Dichloromethane | 2.63 ± 0.28 | 1.83 ± 0.24 | 1.02 ± 0.23 | 0.83 ± 0.03 | 6.31 ± 0.20 |
| Ethyl acetate | 0.86 ± 0.13 | 15.43 ± 0.62 | 1.62 ± 0.21 | 1.52 ± 0.18 | 19.43 ± 0.29 |
| Acetone | 2.84 ± 0.62 | 3.85 ± 0.62 | 4.24 ± 0.24 | 6.21 ± 0.36 | 17.14 ± 0.46 |
| Ethanol | 12.43 ± 0.52 | 3.85 ± 0.62 | 3.71 ± 0.48 | 13.63 ± 0.33 | 33.62 ± 0.49 |
| Methanol | 3.73 ± 0.42 | 6.27 ± 0.38 | 3.30 ± 0.38 | 14.49 ± 0.62 | 27.76 ± 0.45 |
Results are expressed as micrograms of each compound in kilogram of extract.
Figure 1Chemical structures of epicatechin (1), chlorogenic acid (2), hyperoside (3), and procyanidin B2 (4) from C. pinnatifida.
The antioxidant activities of isolated components from Crataegus pinnatifida determined by DPPH, ABTS, superoxide, and hydroxyl radical scavenging and FRAP assays.
| Compounds | DPPH | ABTS | Superoxide | Hydroxyl | FRAP (mM/g) |
|---|---|---|---|---|---|
| Hyperoside | 5.29 ± 0.17 ** | 18.00 ± 0.16 * | 10.59 ± 0.22 ** | N.A. | 7726.67 ± 39.97 |
| Epicatechin | 2.53 ± 0.25 * | 3.75 ± 0.03 ** | 41.56 ± 0.20 * | 20 ± 3.49 | 13,165.19 ± 42.42 |
| Chlorogenic acid | 4.85 ± 0.11 ** | 8.68 ± 0.08 * | 99.62 ± 1.862 * | 18.38 ± 0.56 ** | 3684.74 ± 34.19 |
| Procyanidin B2 | 2.81 ± 0.08 * | 2.91 ± 0.57 ** | 37.22 ± 0.63 * | 13.69 ± 1.88 ** | 11,092.44 ± 32.92 |
| BHT a | 24.04 ± 4.40 ** | 16.13 ± 3.29 *** | N.A. c | 60.62 ± 2.58 * | 4257.97 ± 44.90 ** |
Results are expressed as half inhibitory concentration (IC50) of each free-radical scavenging activity. a Butylated hydroxytoluene (BHT) used as positive control. b FRAP was expressed in mM of Trolox equivalents (TE) per gram of extract. c N.A. indicates not available; * p < 0.05, ** p < 0.01, and *** p < 0.001 compared with the control.
α-Glucosidase inhibitory activities of isolated compounds.
| Extracting Solvents | α-Glucosidase |
|---|---|
| Epicatechin | 81.79 ± 6.94 * |
| Chlorogenic acid | 170.37 ± 10.68 |
| Hyperoside | 34.98 ± 0.89 ** |
| Procyanidin B2 | 118.44 ± 7.34 |
| Acarbose a | 317.80 ± 16.36 * |
a Acarbose used as positive control; * p < 0.05 and ** p < 0.01 compared with the control.
Figure 2The structures of acarbose (a) and hyperoside (b).
Figure 3Interaction of hyperoside with active sites of S. cerevisiae α-glucosidase. The docking model between hyperoside and α-glucosidase (a). The hydrophilic binding mode between hyperoside and α-glucosidase (b).